ESMO: Lantheus' phase 3 radiotherapy readout not enough to topple Pluvicto, say analysts

0

16.09.2024 15:17

Fiercebiotech.com

ESMO: Lantheus' phase 3 radiotherapy readout not enough to topple Pluvicto, say analysts jwaldron Mon, 09/16/2024 - 08:17